Pristimerin Suppresses RANKL-Induced Osteoclastogenesis and Ameliorates Ovariectomy-Induced Bone Loss

Osteoporosis is characterized by bone loss and destruction of trabecular architecture, which greatly increases the burden on the healthcare system. Excessive activation of osteoclasts is an important cause of osteoporosis, and suppression of osteoclastogenesis is helpful for the treatment of osteopo...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Front Pharmacol
Egile Nagusiak: Qi, Dahu, Liu, Hui, Sun, Xuying, Luo, Danni, Zhu, Meipeng, Tao, Tenghui, Gao, Chenghao, Zhou, Chuankun, Zhou, Wei, Xiao, Jun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2021
Gaiak:
Pharmacology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7898668/
https://ncbi.nlm.nih.gov/pubmed/33628184
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.621110
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak